High Quality Content by WIKIPEDIA articles Lorcaserin (APD-356,
expected trade name Lorqess) is a weight-loss drug developed by
Arena Pharmaceuticals. It has serotonergic properties and acts as
an anorectic. On 22 December 2009 a New Drug Application (NDA) was
submitted to the Food and Drug Administration (FDA) in the United
States and lorcaserin is pending approval as of September 2010. On
16 September, an FDA advisory panel voted to recommend against
approval of the drug based on concerns over both safety and
efficacy. In October 2010, the FDA stated that it that it could not
approve the application for lorcaserin in its present form.
Book on Demand
|Country of origin:
• Ronald Cohn
||210 x 150 x 9mm (L x W x T)
||Paperback - Trade
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!